Clinical trial

MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery

NCT02408393

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-03-27

PhasePHASE3

Study timeline

Study start (actual)2015-03-27Date precision: day

Registry last updated2019-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Malignant Neoplasm of Breastunresolved

Interventions

SalineDRUG

RopivacaineDRUG · verified · RxNorm: ropivacaine

Sponsors & collaborators

Institut Curielead sponsor

Mapped research locations

ParisFrance1 LyonFrance1 NiceFrance1 Clermont-FerrandFrance1 Vandœuvre-lès-NancyFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02408393 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.